ro 31-8220 has been researched along with Leukemia, Monocytic, Acute in 1 studies
Ro 31-8220: a protein kinase C inhibitor
Leukemia, Monocytic, Acute: An acute myeloid leukemia in which 80% or more of the leukemic cells are of monocytic lineage including monoblasts, promonocytes, and MONOCYTES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dieter, P | 1 |
| Schwende, H | 1 |
1 other study available for ro 31-8220 and Leukemia, Monocytic, Acute
| Article | Year |
|---|---|
Protein kinase C-alpha and -beta play antagonistic roles in the differentiation process of THP-1 cells.
Topics: Blotting, Western; Cell Differentiation; Cell Division; Enzyme Inhibitors; Humans; Indoles; Isoenzym | 2000 |